Five Year Results of Short Course Complete Androgen Blockade With Abiraterone Acetate and LHRH Agonist for Unfavorable Intermediate and Favorable High Risk Prostate Cancer
- Resource Type
- Abstract
- Source
- In
International Journal of Radiation Oncology, Biology, Physics 1 November 2021 111(3) Supplement:e281-e281 - Subject
- Language
- ISSN
- 0360-3016